The revenue cycle company wants to automate claims processing, and R1 is banking that Humata’s track record of streamlining medical preapprovals should help further that goal.
R1 drills down on AI prior authorizations with Humata buy
The revenue cycle company wants to automate claims processing, and R1 is banking that Humata’s track record of streamlining medical preapprovals should help further that goal.
Source: Healthcare Dive